Failure to Protect Residents from Misappropriation of Controlled Medications
Summary
The facility failed to protect residents from the misappropriation of their medications, specifically controlled substances such as Oxycodone and Percocet, as evidenced by multiple incidents involving six residents. In several cases, narcotic audits revealed missing doses, incomplete or missing documentation, and discrepancies between medication administration records (MARs) and narcotic proof of use sheets. For example, one resident with osteomyelitis and diabetes did not receive a scheduled dose of Oxycodone, despite documentation indicating it had been administered, and the resident confirmed not receiving the medication. Another resident with dementia and osteoarthritis was documented as having received Oxycodone by an LPN, but both the resident and the MAR did not support this, and the resident reported only receiving non-narcotic pain relievers. Additional incidents included missing blister packs and documentation sheets for controlled medications, with audits showing unrecovered quantities of Oxycodone for several residents. In one case, a resident's medication was discontinued, but the remaining tablets were not returned or accounted for, and no notification was made to nursing management. Interviews with residents, some of whom were cognitively intact, consistently indicated that they had not received the narcotic medications as documented, or had not required such medications for pain management. In several instances, the only nurse involved in the administration and documentation of these medications was the same LPN. The facility's internal investigation and interviews with staff revealed that the process for receiving and documenting controlled medications was not consistently followed, leading to the loss and misappropriation of resident medications. The facility's policy defined misappropriation as the wrongful use of resident property, and the events described in the report demonstrate a failure to safeguard residents' medications from deliberate misplacement or unauthorized use. The incidents were reported to appropriate authorities, but the deficiencies stemmed from failures in medication handling, documentation, and oversight.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release July 29, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.